XML 27 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727

Abeona Therapeutics LLC Acquisition (Tables)

6 Months Ended

Jun. 30, 2015

Abeona Therapeutics LLC Acquisition [Abstract]

Schedule of purchase price allocation

Total purchase price
Initial consideration		$	31,758,000
Contingent consideration			6,489,000
Total purchase price		$	38,247,000
Allocation of the purchase price
Cash		$	3,697,000
Accounts receivable			1,000
Prepaid expenses			28,000
Property and equipment			51,000
Other assets			1,000
Accounts payable			(153,000	)
Total tangible assets			3,625,000
Licensing agreement			2,156,000
Goodwill			38,955,000
Contingent consideration liability			(6,489,000	)
Total net asset value		$	38,247,000

X

- References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 805



-SubTopic 20



-Section 50



-Paragraph 1



-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4845-128472

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration